-
今开：--
昨收：--
-
今日区间：--
52周区间：--
-
成交量：--
成交额：--
-
市 值：--
市盈率：--
-
振幅：
每股收益：
成交量
董事会
- Michael F. Mahoney
- Michael F. Mahoney is currently Chairman, President & Chief Executive Officer at Boston Scientific Corp. since 2016. He is Chief Executive Officer at EndoChoice, Inc., Boston Scientific Scimed, Inc., Vertiflex, Inc., and Farapulse, Inc. He serves as Member-CEO Roundtable at American Heart Association, Inc. since 2013. He is Chairman-Governors Board at Boston College Ceo Club. He is Lead Independent Director at CVS Health Corp. starting 2023. He holds director positions at Advanced Medical Technology Association, Baxter Healthcare Pty Ltd., Baxter SpA since 2015, VisionBank of Iowa, Baxter Healthcare Ltd. (United Kingdom) since 2015, AdvaMed Accel, VisionBankshares, Inc., and Boys & Girls Club of Boston. He is President at Corvita Corp., Lumenis, Inc., and Boston Scientific Cardiac Diagnostics, Inc. (Texas). Formerly, Mr. Mahoney was Chief Executive Officer at CEO Roundtable LLC, IntElect Medical, Inc., IoGyn, Inc., Cryterion Medical, Inc. He was President & Chief Executive Officer at Global Healthcare Exchange LLC from 2001 to 2007. He was Worldwide Group Chairman at DePuy Orthopaedics, Inc. He was Chairman-Worldwide Medical Devices & Diagnostics at Johnson & Johnson from 2009 to 2011. He was Independent Director at Baxter International, Inc. from 2015 to 2023 and also served as Director there. He was General Manager-Healthcare Information Technology at GE Medical Systems, Inc. He was President at Augmenix, Inc.Education includes an MBA from Wake Forest University and undergraduate studies at the University of Iowa.
-
- Joseph M. Fitzgerald
- Joseph M. Fitzgerald is Executive VP & Group President-Cardiology at Boston Scientific Corp. since 2022. Former roles include Director-Business Intelligence at Anheuser Busch, Inc., President at CryoCor, Inc., and Vice President-Global Marketing at NeuroVascular Recovery Ltd. from 1997 to 2005. Education includes undergraduate studies at Indiana University and an MBA from Southern Illinois University.
-
- John Edward Sununu
- John Edward Sununu is currently an Independent Director at Boston Scientific Corp., a Director at ConvergEx, Inc., a Director at Juliet Marine Systems, Inc., a Director at Afiniti Ltd. (Bermuda), an Independent Director at BlueRiver Acquisition Corp., a Director at Sorenson Communications LLC, and a Director & Council member at Lloyd's of London Ltd. He previously served as an Independent Director at Time Warner Cable, Inc. from 2009 to 2016. He also held positions as a Director at Melinta Subsidiary Corp., a Director at Afiniti, Inc., and a Member of the U.S. House of Representatives from 1996 to 2002. Prior to that, he was the Chief Financial Officer at Teletrol Systems, Inc. Mr. Sununu received his undergraduate degree from Massachusetts Institute of Technology, his graduate degree from Massachusetts Institute of Technology in 1987, and his MBA from Harvard Business School in 1991.
-
- Michael F. Mahoney
- Michael F. Mahoney is currently Chairman, President & Chief Executive Officer at Boston Scientific Corp. since 2016. He is Chief Executive Officer at EndoChoice, Inc., Boston Scientific Scimed, Inc., Vertiflex, Inc., and Farapulse, Inc. He serves as Member-CEO Roundtable at American Heart Association, Inc. since 2013. He is Chairman-Governors Board at Boston College Ceo Club. He is Lead Independent Director at CVS Health Corp. starting 2023. He holds director positions at Advanced Medical Technology Association, Baxter Healthcare Pty Ltd., Baxter SpA since 2015, VisionBank of Iowa, Baxter Healthcare Ltd. (United Kingdom) since 2015, AdvaMed Accel, VisionBankshares, Inc., and Boys & Girls Club of Boston. He is President at Corvita Corp., Lumenis, Inc., and Boston Scientific Cardiac Diagnostics, Inc. (Texas). Formerly, Mr. Mahoney was Chief Executive Officer at CEO Roundtable LLC, IntElect Medical, Inc., IoGyn, Inc., Cryterion Medical, Inc. He was President & Chief Executive Officer at Global Healthcare Exchange LLC from 2001 to 2007. He was Worldwide Group Chairman at DePuy Orthopaedics, Inc. He was Chairman-Worldwide Medical Devices & Diagnostics at Johnson & Johnson from 2009 to 2011. He was Independent Director at Baxter International, Inc. from 2015 to 2023 and also served as Director there. He was General Manager-Healthcare Information Technology at GE Medical Systems, Inc. He was President at Augmenix, Inc.Education includes an MBA from Wake Forest University and undergraduate studies at the University of Iowa.
-
- Edward J. Ludwig
- Edward J. Ludwig currently works at POCARED Diagnostics Ltd., as Chairman, GRIP Molecular Technologies, Inc., as Chairman from 2021, Boston Scientific Corp., as Lead Independent Director from 2016, Center For Higher Ambition, as Director, and The Johns Hopkins University, as Trustee. Mr. Ludwig also formerly worked at Becton, Dickinson & Co., as Chairman & Chief Executive Officer from 2008 to 2011, HMH Hospitals Corp, Inc., as Vice Chairman from 2013 to 2015, Aetna, Inc., as Independent Director from 2011 to 2014, Advanced Medical Technology Association, as Director from 2006 to 2008, Xylem, Inc., as Independent Director from 2011 to 2017, CVS Health Corp., as Independent Director from 2018 to 2024, College of the Holy Cross (Massachusetts), as Trustee from 2005 to 2013, Coopers & Lybrand LLP, as Senior Auditor, and Columbia Business School, as Member-Overseers Board from 2010 to 2015. Mr. Ludwig received his undergraduate degree from College of the Holy Cross (Massachusetts) and Masters Business Admin degree from Columbia Business School.
-
- Ellen M. Zane
- Ellen M. Zane currently works at The Floating Hospital, Inc., as President & Chief Executive Officer from 2004 to 2011, Tufts Medical Center, Inc., as President & Chief Executive Officer from 2004 to 2011, Haemonetics Corp., as Chairman from 2021, George Washington University, as Vice Chairman, Tufts Medicine, Inc., as Chairman, Medical Faculty Associates, Inc., as Chairman, Boston Scientific Corp., as Independent Director from 2016, Massachusetts Development Finance Agency, as Director, National Association of Corporate Directors, New England CH*, as Director, Synchrony Financial, as Independent Director from 2016, AgNovos Healthcare LLC, as Director, Fiduciary Co., Inc., as Director, FinThrive, Inc., as Director from 2018, Savista LLC (Georgia), as Director, Synchrony Bank, as Director from 2022, and Newbridge on the Charles, Inc., as Trustee. Dr. Zane also formerly worked at Quincy Hospital, as Chief Executive Officer, Floating Hospital For Children, as President & Chief Executive Officer from 2004 to 2011, Massachusetts Health & Hospital Association, Inc., as Chairman in 2010, Minuteman Health, Inc., as Chairman, Lincare Holdings, Inc., as Independent Director from 2011 to 2012, Azenta, Inc., as Independent Director from 2012 to 2024, Haemonetics Corp., as Independent Director from 2012 to 2016, PAREXEL International Corp., as Director from 2015 to 2017, Fiduciary Trust Co., as Director, Variagenics, Inc., as Director, Press Ganey Associates, as Director, United Way of Massachusetts Bay & Merrimack Valley, as Director, Century Capital Management, Inc., as Director, MassDevelopment, as Director, Press Ganey Associates LLC, as Independent Director from 2012 to 2016, Mass General Brigham, Inc., as Network President from 1994 to 2004, and Tufts University School of Medicine, as Assistant Professor. Dr. Zane received her undergraduate degree in 1973 from George Washington University and graduate degree in 1975 from The Catholic University of America.
-
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
- Yoshiaki Fujimori
- Yoshiaki Fujimori is Independent Outside Chairman at Oracle Corp Japan since 2018. Holds the position of Chairman at Novapar SA. Independent Director at Boston Scientific Corp. since 2016. Independent Outside Director at Takeda Pharmaceutical Co., Ltd. since 2016. Representative Director at GraceA, Inc. since 2014. Outside Director at JTOWER, Inc. Director at Sogo Medical Co., Ltd. Independent Director at Blaize Holdings, Inc. starting 2025. Senior Adviser at CVC Asia Pacific (Japan) KK since 2017. Trustee at Tepper School of Business. Formerly President, Chief Executive Officer & Director at LIXIL Corp. from 2011 to 2016. President & Chief Executive Officer at GE Medical Systems, Inc. President & Chief Executive Officer at GE Plastics in 2003. President & Chief Executive Officer at General Electric Japan Corp. from 1986 to 2011. President & Chief Executive Officer at GE Money Asia. Chief Executive Officer at GE Healthcare Asia from 2008 to 2011. Independent Director at Tokyo Electric Power Co. Holdings, Inc. Independent Director at Toshiba Corp. from 2019 to 2021. Outside Director at HITOWA Holdings Co. Ltd. Director at Japan Construction Material & Housing Equipment Industries Federation. Independent Director at Shiseido Co., Ltd. from 2020 to 2022. Senior Vice President at GE Aerospace. Senior Vice President at General Electric Co. Education includes undergraduate studies at Tokyo University of Science and an MBA from Tepper School of Business conferred in 1981.
-
- David Scott Wichmann
- David Scott Wichmann currently serves as Independent Director at Boston Scientific Corp. since 2021, Director at Minnesota Orchestral Association, Director at Vytalize Health, Inc. since 2023, and Independent Director at Privia Health Group, Inc. since 2023. Former roles include Chief Executive Officer & Director at UnitedHealth Group, Inc. from 2017 to 2021, Chief Executive Officer-Specialized Care Services at OptumHealth, Inc. from 2004 to 2013, Chairman at Council for Affordable Quality Healthcare, Inc., Independent Director at Tennant Co., Partner at Arthur Andersen LLP from 1995 to 1998, CFO, President-Operations & Technology at UnitedHealthcare, Inc. in 2006, and Chief Financial Officer at Advance Machine Co. in 1994. Education includes undergraduate studies at Illinois State University.
-
- Jessica L. Mega
- Jessica L. Mega was the founder of Verily Life Sciences LLC, founded in 2015, where the title held was Chief Medical & Scientific Officer from 2015 to 2023. The current job is Independent Director at Boston Scientific Corp. starting in 2023. Former job includes Independent Director at Danaher Corp. from 2019 to 2026. Education history includes an undergraduate degree from Stanford University conferred in 1996, a graduate degree from Harvard T.H. Chan School of Public Health, and a doctorate from Yale School of Medicine.
-
- Susan E. Morano
- Susan E. Morano currently works at Boston Scientific Corp., as Independent Director from 2023. Ms. Morano also formerly worked at Cutanea Life Sciences, Inc., as Director-Clinical Operations, Fibrocell Science, Inc., as Senior Manager-Medical Affairs in 2005, Dermik Laboratories, Inc., as Manager-Scientific Communications in 2004, and Johnson & Johnson, as VP-Business Development & Strategic Operations from 2020 to 2023. Ms. Morano received her undergraduate degree from Villanova University and Masters Business Admin degree from Columbia Business School.
-
- Cheryl Pegus
- Dr. Cheryl B. Pegus, MD, is an Independent Director at Concentra Group Holdings Parent, Inc., an Independent Director at Boston Scientific Corp., a President-Consumer Health Solutions at Cambia Health Solutions, Inc., a Chairman & Chief Executive Officer at Intellihealth, Inc., a Member-Deans Circle at Weill Cornell Medical College and a Professor-Medicine & Population Health at New York University School of Medicine. She is on the Board of Directors at Concentra Group Holdings Parent, Inc., Boston Scientific Corp., Association of Black Cardiologists, American Heart Association, Inc. and Zillion Group, Inc. Dr. Pegus was previously employed as an Executive Vice President-Health & Wellness by Walmart, Inc., an Independent Director by Phreesia, Inc., an Independent Director by Tactile Systems Technology, Inc., a Lead Independent Director by Vision-Sciences, Inc., a President by Caluent LLC, an Independent Director by Cogentix Medical, Inc., a Chief Medical Officer by Walgreen Co., a Chief Medical Officer & General Manager by Symcare Personalized Health Solutions, Inc., a Head-Clinical Products by Aetna, Inc., a Director-General Internal Medicine by NYU Langone Health, a Medical Director-Cardiovascular Risk Factors Group by Pfizer Pharmaceuticals, Inc., and a Chief Medical Officer by Take Care Health Systems LLC. She also served on the board at U.S. Acute Care Solutions LLC, Ulta Salon, Cosmetics & Fragrance, Inc., Aseko, Inc., Business Group on Health, Care Continuum Alliance and Glytec LLC. She received her undergraduate degree from Brandeis University, a graduate degree from Joseph L. Mailman School of Public Health and a doctorate degree from Weill Cornell Medical College.
-
- David C. Habiger
- David C. Habiger founded Providence Productions in 1991 and Silicon Media Partners LLC in 2016, where he worked as Partner. Mr. Habiger also currently works at NDS Group Holdings Ltd., as Chief Executive Officer & Director from 2011, Liftoff Mobile, Inc., as Chairman from 2025, J.D. Power, as Vice Chairman from 2025, and various other companies. Mr. Habiger also formerly worked at Sonic Solutions LLC, as President & Chief Executive Officer from 2005 to 2010, NDS Group Ltd., as Chief Executive Officer & Director from 2011 to 2012, Textura Corp., as Chief Executive Officer & Director from 2015 to 2016, and various other companies. Mr. Habiger received his Masters Business Admin degree in 1998 from The University of Chicago and undergraduate degree in 1991 from St. Norbert College, Inc.
-
- Catherine R. Smith
- Catherine R. Smith is currently an Independent Director at PPG Industries, Inc. since 2019, a Director at Boston Scientific Corp. starting in 2026, a Director at The Curtis L. Carlson School of Management, a Director at Baxter Healthcare Ltd. (United Kingdom) since 2017, a Director at Baxter SpA, a Director at Baxter Healthcare Pty Ltd., and Chief Financial Officer & Executive Vice President at Starbucks Corp. starting in 2025. Former positions include Director at Wal-Mart de M xico SAB de CV from 2010 to 2014, Director at Dick's Sporting Goods, Inc. from 2009 to 2010, Independent Director at Baxter International, Inc. from 2017 to 2026, Chief Financial Officer & Executive Vice President at Centex Corp. in 2009, Chief Financial Officer & Executive Vice President at Kennametal, Inc. from 2005 to 2006, CFO and VP-Intelligence & Information Systems at Raytheon Co. in 2003, Chief Financial Officer & EVP-Bell Systems at Textron, Inc. from 2003 to 2005, Chief Financial Officer & Executive Vice President at Express Scripts, Inc. from 2014 to 2015, Chief Financial Officer & Executive Vice President at Target Corp. from 2015 to 2019, Chief Financial Officer & Executive Vice President at GameStop Corp. from 2009 to 2010, Chief Financial Officer & Executive Vice President at Evernorth Health, Inc. from 2014 to 2015, Chief Financial Officer & Executive Vice President at Wal-Mart International from 2010 to 2014, Chief Financial Officer & Executive Vice President at Bell Textron, Inc. in 2009, Chief Financial & Administrative Officer at NeueHealth, Inc. from 2020 to 2023, and Chief Financial Officer, Treasurer & Executive VP at Nordstrom, Inc. from 2023 to 2025. Education includes undergraduate studies at the University of California, Santa Barbara and an MBA from USC Marshall School of Business.
-
- Christophe Weber
- Christophe Weber currently works at Takeda Pharmaceutical Co., Ltd., as President, CEO & Representative Director from 2024, Millennium Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2014, Boston Scientific Corp., as Director from 2026, Longwood Fund Management LLC, as Advisor, and Takeda Italia SpA, as President. Dr. Weber also formerly worked at GlaxoSmithKline Biologicals SA, as Chief Executive Officer, Takeda Pharmaceuticals (Asia Pacific) Pte Ltd., as President & Chief Executive Officer, Groupe GlaxoSmithKline SAS, as Chairman & Chief Executive Officer, and GlaxoSmithKline Pharmaceuticals SA (Belgium), as President & General Manager-Vaccines Division. Dr. Weber received his graduate degree and doctorate degree from the University of Lyon, undergraduate degree from Universit Jean Moulin Lyon 3, and graduate degree from Universite Lumiere Lyon 2.
-